Hans Neubauer
Efficacy of Lapatinib in Patients with HER2-Negative Metastatic Breast Cancer and HER2-Positive Circulating Tumor Cells-The DETECT III Clinical Trial.
Fehm T, Müller V, Banys-Paluchowski M, Fasching P, Friedl T, Hartkopf A, Huober J, Loehberg C, Rack B, Riethdorf S, Schneeweiss A, Wallwiener D, Meier-Stiegen F, Krawczyk N, Jaeger B, Reinhardt F, Hoffmann O, Müller L, Wimberger P, Ruckhäberle E, Blohmer J, Cieslik J, Franken A, Niederacher D, Neubauer H, Pantel K, Janni W, DETECT study group. Efficacy of Lapatinib in Patients with HER2-Negative Metastatic Breast Cancer and HER2-Positive Circulating Tumor Cells-The DETECT III Clinical Trial. Clin Chem 2024; 70:307-318.
04.01.2024Efficacy of Lapatinib in Patients with HER2-Negative Metastatic Breast Cancer and HER2-Positive Circulating Tumor Cells-The DETECT III Clinical Trial.
04.01.2024Clin Chem 2024; 70:307-318
Fehm Tanja N, Müller Volkmar, Banys-Paluchowski Maggie, Fasching Peter Andreas, Friedl Thomas Wolfram Paul, Hartkopf Andreas D, Huober Jens, Loehberg Christian R, Rack Brigitte, Riethdorf Sabine, Schneeweiss Andreas, Wallwiener Diethelm, Meier-Stiegen Franziska, Krawczyk Natalia, Jaeger Bernadette, Reinhardt Florian, Hoffmann Oliver, Müller Lothar, Wimberger Pauline, Ruckhäberle Eugen, Blohmer Jens-Uwe, Cieslik Jan-Philipp, Franken André, Niederacher Dieter, Neubauer Hans, Pantel Klaus, Janni Wolfgang, DETECT study group
Changes in tumour biological markers during primary systemic chemotherapy (PST)
Hornung R, Neubauer H, Gall C, Vogel U, Wallwiener D, Solomayer E, Fehm T. Changes in tumour biological markers during primary systemic chemotherapy (PST). International Institute of Anticancer Research 2008; 28:1797-1804.
03.03.2008Changes in tumour biological markers during primary systemic chemotherapy (PST)
03.03.2008International Institute of Anticancer Research 2008; 28:1797-1804
Hornung René, Neubauer Hans, Gall Christian, Vogel Ulrich, Wallwiener Diethelm, Solomayer Erich, Fehm Tanja
Comparison of HER2 status between primary tumor and disseminated tumor cells in primary breast cancer patients
Solomayer E, Huober J, Wallwiener D, Neubauer H, Vogel U, Krämer B, Bachmann R, Pergola-Becker G, Becker S, Fehm T. Comparison of HER2 status between primary tumor and disseminated tumor cells in primary breast cancer patients. Breast cancer research and treatment 2006; 98:179-84.
01.07.2006Comparison of HER2 status between primary tumor and disseminated tumor cells in primary breast cancer patients
01.07.2006Breast cancer research and treatment 2006; 98:179-84
Solomayer Erich F, Huober Jens, Wallwiener Diethelm, Neubauer Hans, Vogel Ulrich, Krämer Bernhard, Bachmann Robert, Pergola-Becker Graziella, Becker Sven, Fehm Tanja N